Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study

Background: Infusion reactions (IRs) are the most common adverse events (AEs) of infliximab (IFX) treatment in patients with inflammatory bowel disease (IBD). Prophylactic premedication (PM) with corticosteroids or antihistamines prior to IFX infusions has been used in clinical practice, but its eff...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Med
Main Authors: Szymanska, Edyta, Dadalski, Maciej, Sieczkowska-Golub, Joanna, Jarzebicka, Dorota, Meglicka, Monika, Osiecki, Marcin, Wiernicka, Anna, Lebensztejn, Dariusz M., Korczowski, Bartosz, Kierkus, Jaroslaw
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303466/
https://ncbi.nlm.nih.gov/pubmed/34300342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10143177
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker